News
UC Davis Health is unveiling two brand-new initiatives -- the Health Venture Studio and the Investing in the Future of ...
Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 26,191.09 Crore) operating in Hospitals & Allied Services sector. Krishna ...
Shares Genomics Immunology and Healthcare ETF offers biotech exposure but lacks performance and stability versus PBE. Find ...
April 07, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon ... M.D., has been appointed chief medical officer of the company, effective April 9, 2025. With the appointment ...
Bad Homburg v. d. Höhe, April 7, 2025 – RNA researcher Anastasia Khvorova, PhD, professor of RNA therapeutics at UMass Chan Medical School, will receive this year's Else Kröner Fresenius Prize ...
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ ... Zimmermann Professor of Neurology & Neurological Sciences, and Pediatrics at Stanford University. Additional information ...
The Lower the ApoB, the Better: Now, How Does ApoB Fit in the Upcoming Era of Targeted Therapeutics?
The study does not provide convincing evidence that on-treatment apoB is superior to non–HDL-C in predicting residual risk in this population. In the continuous spline analyses, the authors show that ...
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Elicio Therapeutics (ELTX) been one of those stocks this ...
This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada. "By selecting only the genetics that deliver an elevated ...
Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels ...
A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...
Dura Medical Founder Stephen Durand will be named director of ... and Matthew Duffy, co-CEOs of HOPE Therapeutics. NRx recently announced the initiation of filing a New Drug Application for NRX-100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results